XML 32 R21.htm IDEA: XBRL DOCUMENT
v3.21.2

Segment Information | 6 Months Ended
--- | ---
Jun. 30, 2021
Segment Reporting [Abstract] |
Segment Information | Note 14 – Segment Information The Company has identified two operating segments, diagnostic services and consumer products, based on the manner in which the Company’s CEO as CODM assesses performance and allocates resources across the organization. The operating segments are organized in a manner that depicts the difference in revenue generating synergies that include the separate processes, profit generation and growth of each segment. The diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third party payers and government organizations. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States. The unallocated corporate expenses mainly included professional fees associated with the public company. The following table is a summary of segment information for three and six months ended June 30, 2021 and 2020 (amounts in thousands): Schedule of Segment Information
|  | June 30, 2021 |  |  | June 30, 2020 |  |  | June 30, 2021 |  |  | June 30, 2020 |
|  | For the three months ended |  |  | For the six months ended |
|  | June 30, 2021 |  |  | June 30, 2020 |  |  | June 30, 2021 |  |  | June 30, 2020 |
Net revenues |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Diagnostic services |  | $ | 7,537 |  |  | $ | - |  |  | $ | 20,274 |  |  | $ | - |
Consumer products |  |  | 1,605 |  |  |  | 3,623 |  |  |  | 4,139 |  |  |  | 5,511 |
Consolidated net revenue |  |  | 9,142 |  |  |  | 3,623 |  |  |  | 24,413 |  |  |  | 5,511 |
Cost of revenue |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Diagnostic services |  |  | 3,479 |  |  |  | - |  |  |  | 7,824 |  |  |  | - |
Consumer products |  |  | 1,197 |  |  |  | 2,344 |  |  |  | 3,196 |  |  |  | 3,817 |
Consolidated cost of revenue |  |  | 4,676 |  |  |  | 2,344 |  |  |  | 11,020 |  |  |  | 3,817 |
Depreciation and amortization expense |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Diagnostic services |  |  | 392 |  |  |  | - |  |  |  | 737 |  |  |  | - |
Consumer products |  |  | 3 |  |  |  | 5 |  |  |  | 6 |  |  |  | 10 |
Total Depreciation and amortization expense |  |  | 395 |  |  |  | 5 |  |  |  | 743 |  |  |  | 10 |
Operating and other expenses |  |  | 5,466 |  |  |  | 1,204 |  |  |  | 12,988 |  |  |  | 2,423 |
Income (loss) from continuing operations, before income taxes |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Diagnostic services |  |  | 1,164 |  |  |  | - |  |  |  | 4,004 |  |  |  | - |
Consumer products |  |  | 540 |  |  |  | 1,274 |  |  |  | 505 |  |  |  | 1,684 |
Unallocated corporate |  |  | (3,099 | ) |  |  | (1,204 | ) |  |  | (4,847 | ) |  |  | (2,423 | )
Total income (loss) from continuing operations, before income taxes |  |  | (1,395 | ) |  |  | 70 |  |  |  | (338 | ) |  |  | (739 | )
Net income (loss) |  | $ | (1,395 | ) |  | $ | 70 |  |  | $ | (338 | ) |  | $ | (739 | )
The following table is a summary of segment balance sheets information as of June 30, 2021 and December 31, 2020 (in thousands):
|  | June 30, |  |  | December 31, |
|  | 2021 |  |  | 2020 |
ASSETS |  |  |  |  |  |  |  |
Diagnostic services |  | $ | 32,222 |  |  | $ | 13,410 |
Consumer products |  |  | 5,294 |  |  |  | 6,261 |
Unallocated corporate |  |  | 38,807 |  |  |  | 11,734 |
Total assets |  | $ | 76,323 |  |  | $ | 31,405 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 34 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 42 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration